Cite Filings / MPLT / 0001193125-26-224129
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

MapLight Therapeutics, Inc. · Filed 2026-05-14 · Acc 0001193125-26-224129

Documents 1

  • 10-Q Quarterly Report , mplt-20260331.htm

Around this filing

  • 2026-08-13 10-Q Quarterly Report
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-14 10-Q Quarterly Report
  • 2026-05-14 8-K Results of operations · Regulation FD disclosure
  • 2026-05-11 4 General Counsel sold 13,917 shares at an average $30.13 ($419,263)
  • 2026-05-11 4 Chief Executive Officer sold 68,491 shares at an average $28.47 ($1,949,634)
  • 2025-12-04 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading mplt-20260331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…